FIRST TRUST ADVISORS LP

Position in HROW — Harrow, Inc.

CIK 1125816 Wheaton, IL

Position in HROW

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$4,260,378

-$1,173,046 QoQ

Shares Held

100,315

-34.9% QoQ

Ownership

0.268%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#33

of 223 holders

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 65% Shared 0% None 35%

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. HROW ranks #16 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	923,125	$155,583,487
2	UTHR	UNITED THERAPEUTICS Corp	249,056	$134,946,012
3	ALKS	Alkermes plc.	2,421,016	$126,861,238
4	ZTS	Zoetis Inc.	1,435,652	$103,165,952
5	TAK	Takeda Pharmaceutical Co Ltd	2,114,912	$33,902,039
6	LQDA	Liquidia Corp	301,432	$24,033,173
7	BCRX	Biocryst Pharmaceuticals Inc	1,120,469	$11,204,690
8	AMRX	Amneal Pharmaceuticals, Inc.	614,206	$10,631,905

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,260,378	100,315	-34.9%	Shares	Sole	2026-08-11
2026-03-31	$5,433,424	154,096	+1.2%	Shares	Sole	2026-05-13
2025-12-31	$7,459,319	152,231	-6.1%	Shares	Sole	2026-02-13
2025-09-30	$7,808,628	162,072	+95.0%	Shares	Sole	2025-11-12
2025-06-30	$2,538,820	83,131	+129.0%	Shares	Sole	2025-08-13
2022-06-30	$264,271	36,301	-2.2%	Shares	Sole	2022-08-12
2022-03-31	$253,172	37,122	-5.5%	Shares	Sole	2022-05-13
2021-12-31	$339,353	39,277	+14.1%	Shares	Sole	2022-02-08
2021-09-30	$312,805	34,412	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.